Answers are grounded in this paper and cite their sources.
Limited evidence is available on the real-world effect of insulin degludec (IDeg) in type 1 diabetes (T1D), using continuous glucose monitoring (CGM)-derived metrics.
No takes yet. Share an insight, caveat, or question.
Groote et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: